# Third Culture Capital

Third Culture Capital is a Private Equity based in Boston, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Boston, MA, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** www.thirdculturecapital.com
- **LinkedIn:** https://www.linkedin.com/company/thirdculturecapital

## Regulatory record

- **Reports private funds:** No

## About

Third Culture Capital invests at the confluence of healthcare, technology, and access. The firm backs early-stage, healthcare-native startups and unconventional founders with a Third Culture mindset. It evaluates investments against the Quintuple Aim and focuses on improving how care is delivered, accessed, and experienced across real-world systems.

## Sectors

- Digital Health
- Enterprise Software
- AI/ML

## People

- Julien L. Pham — Founder & Managing Partner

## Questions

### Who makes investment decisions at Third Culture Capital?

Investment decisions are led by Julien Pham, the firm's Founder and Managing Partner. Pham is a practicing nephrologist at Brigham and Women's Hospital in Boston, which gives him direct clinical-operational context when evaluating health-tech startups. The firm has not publicly disclosed additional investment committee members or junior partners.

### How does Third Culture Capital source its deal flow?

The firm's deal flow is rooted in Pham's dual identity as a clinician and investor. Sourcing channels include academic medical center networks, clinical professional societies, health-tech founder communities, and referrals from other physician-investors. This model gives early access to clinician-founders who are solving workflow problems that are invisible to non-clinical investors.

### Does Third Culture Capital invest outside the United States?

The firm's primary focus is US innovation hubs — Boston, San Francisco, and New York — where the density of academic medical centers and health-tech founders is highest. Pham has evaluated deals in Toronto and London, but no cross-border portfolio companies have been confirmed as core positions.

### How is Third Culture Capital's investment approach different from a typical health-tech venture fund?

The structural differentiator is Pham's ongoing clinical practice. Because he still treats patients at a major teaching hospital, the firm identifies investment opportunities through firsthand experience with clinical workflow failures, reimbursement friction, and regulatory gaps that generalist VCs only hear about secondhand. This physician-operator model is rare among institutional venture firms.

## Related profiles

- [Third Craft](https://altss.com/profile/third-craft)
- [Third Derivative](https://altss.com/profile/third-derivative)

---

Source record modified: 2026-08-11T15:08:18.003Z

Last verified: not supplied by this public snapshot.

## Sources and provenance

- Organization website as recorded: https://www.thirdculturecapital.com/
Source links do not imply that every field was verified on the page modification date. See [Altss methodology](https://altss.com/methodology).

Canonical page: https://altss.com/profile/third-culture-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology